Introduction: The United States Medical Licensing Examination (USMLE) was designed as a universal assessment tool for states to determine physician's medical licensure's candidacy. Recent changes in the USMLE exam have changed the way future surgical residency candidate applications will be reviewed. The survey aimed to assess the effect of changes in USMLE exams-USMLE Step 1 pass/fail, complete dissolution of USMLE clinical skills exam, and the role of holistic review in future surgical residency candidacy selection.
Methods: An anonymous online survey was created and distributed to general surgery program directors and coordinators across the USA. The survey aimed to assess attitudes toward changes to USMLE exams and the potential changes with a holistic review of candidate applications.
Results: The response rate was 63.7%. Most program directors and coordinators disagree with changing USMLE Step 1 to a pass/fail scoring system. The majority felt that contacts, the medical school's name, and performance in clinical electives and sub-internships would hold more significance. They also believe that a holistic review of application will decrease socioeconomic discrepancies and promote a more diverse and inclusive resident cohort.
Conclusion: Step 2 clinical knowledge (CK) will gain more importance in future residency matches because of the change in the scoring system of Step 1. The medical school's name, personal contacts, and clinical performance in rotations will hold more significance.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325542 | PMC |
| http://dx.doi.org/10.1007/s00268-021-06261-7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A national survey on gastroenterology and hepatology training reveals dissimilar perceptions between trainees and trainers and an important need for improvement in training programs.
Eur J Gastroenterol Hepatol
January 2025
Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna.
Objective: We aimed to collect data on gastroenterology and hepatology training from the viewpoint of trainees and trainers.
Methods: A national online survey was distributed among trainees and specialists at certified training institutions between February and May 2024.
Results: Overall, 226 respondents - 98 trainees, 78 trainers, 50 program directors, and department heads responded, with a national coverage of 70% of trainees and 85% of specialty-department heads.
Case Management Does Matter.
Prof Case Manag
January 2025
Lynn S. Muller, JD, RN, BA-HCM, CCM, began her career at Pace University as a Registered Professional Nurse (RN), went onto earn her Bachelor of Arts Degree in Health Care Management at St. Peter's University of New Jersey and then her Juris Doctor from Quinnipiac University School of Law. She is currently a practicing Attorney and the managing partner of Muller & Muller. Her practice includes the defense of healthcare professionals before the state licensing boards, case management litigation, family law, wills, trusts, and estates, as well as consulting representation of medical practitioners, facilities and health service corporations on such issues as regulatory compliance and day-to-day operations. Dr. Muller is a popular and sought-after keynote and session speaker at national and regional conferences. She is the Contributing Editor of Professional Case Management: The Official Journal of the Case Management Society of America (CMSA), She is a former member of the Board of Directors of CMSA of New York City and a former adjunct Professor at Saint Peter's University School of Nursing in the MSN and DNP Programs. Dr. Muller is the author of over 80 articles in nursing and case management journals and listed on the NIH website. She is a contributor to the 2016 CMSA Standards of Practice and CMSA Career & Knowledge Pathways. Dr. Muller is the author of both legal chapters of the 3rd edition of Case Management: A Practical Guide for Education and Practice and 3rd edition of the CMSA Core Curriculum for Case Management. She is a former Commissioner for the Commission for Case Management Certification (CCMC), where she now serves on the Professional Development and Education Committee, is a Certified Facilitator for CCM CERTIFCATION 360™ a Multi-day Immersion Program and other special projects. She is a contributor to the CCMC Case Management Body of Knowledge (CMBOK) and a past President of the New Jersey Chapter of CMSA. Dr. Muller is the former Director of Social Services for the Borough of Bergenfield, N.J., a community-based case management program she developed and initiated. Dr. Muller has also served her community as public defender, municipal court judge, councilwoman and chaired the Borough's Barrier Free Committee.
Meaningful Medication Reconciliation.
Prof Case Manag
January 2025
Lynn S. Muller, JD, RN, BA-HCM, CCM, began her career at Pace University as a Registered Professional Nurse (RN), went onto earn her Bachelor of Arts Degree in Health Care Management at St. Peter's University of New Jersey and then her Juris Doctor from Quinnipiac University School of Law. She is currently a practicing Attorney and the managing partner of Muller & Muller. Her practice includes the defense of healthcare professionals before the state licensing boards, case management litigation, family law, wills, trusts, and estates, as well as consulting representation of medical practitioners, facilities and health service corporations on such issues as regulatory compliance and day-to-day operations. She is a popular and sought-after keynote and session speaker at national and regional conferences. She is the Contributing Editor of Professional Case Management: The Official Journal of the Case Management Society of America (CMSA), She is a former member of the Board of Directors of CMSA of New York City and a former adjunct Professor at Saint Peter's University School of Nursing in the MSN and DNP Programs. She is the author of over 80 articles in nursing and case management journals and listed on the NIH website. She is a contributor to the 2016 CMSA Standards of Practice and CMSA Career & Knowledge Pathways. She is the author of both legal chapters of the 3rd edition of Case Management: A Practical Guide for Education and Practice and 3rd edition of the CMSA Core Curriculum for Case Management. She is a former Commissioner for the Commission for Case Management Certification (CCMC), where she now serves on the Professional Development and Education Committee, is a Certified Facilitator for CCM CERTIFCATION 360 a Multi-day Immersion Program and other special projects. She is a contributor to the CCMC Case Management Body of Knowledge (CMBOK) and a past President of the New Jersey Chapter of CMSA. She is the former Director of Social Services for the Borough of Bergenfield, NJ, a community-based case management program she developed and initiated. She has also served her community as public defender, municipal court judge, councilwoman and chaired the Borough's Barrier Free Committee.
Hearing Loss and Discrimination: Evidence of Intersectionality in the All of Us Research Program.
Laryngoscope
January 2025
Department of Otolaryngology-Head and Neck Surgery, NewYork-Presbyterian/Columbia University Irving Medical Center, Columbia University Vagelos College of Physicians and Surgeons, 180 Fort Washington Avenue, HP8, New York, New York, 10032, U.S.A.
Objectives: Hearing loss (HL) has significant implications on social functioning. Here, we study the relationship between HL, race, and these combined categories as risk factors for discrimination in the large national All of Us cohort.
Methods: The National Institutes of Health All of Us dataset was analyzed after including individuals who completed the Everyday Discrimination Survey between November 2021 and January 2022.
Desensitization With Imlifidase for HLA-Incompatible Deceased Donor Kidney Transplantation: A Delphi International Expert Consensus.
Transpl Int
January 2025
Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
Highly sensitized (HS) patients in need of kidney transplantation (KTx) typically spend a longer time waiting for compatible kidneys, are unlikely to receive an organ offer, and are at increased risk of antibody-mediated rejection (AMR). Desensitization using imlifidase, which is more rapid and removes total body immunoglobulin G (IgG) to a greater extent than other methods, enables transplantation to occur between HLA-incompatible (HLAi) donor-recipient pairs and allows patients to have greater access to KTx. However, when the project was launched there was limited data and clinical experience with desensitization in general and with imlifidase specifically.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!